Health Care/Hospital

American Public Health Champion Receives 2010 Stockholm Water Prize

STOCKHOLM, March 22 /PRNewswire-Asia/ -- Dr. Rita Colwell, distinguished Professor from the University of Maryland and John Hopkins University's Bloomberg School of Public Health in the United States, has been named the 2010 Stockholm Water Prize Laureate. Dr. Colwell's pioneering research o...

2010-03-22 19:00 717

NeoStem Appoints Deloitte & Touche as New Independent Registered Public Accounting Firm

NEW YORK, March 16 /PRNewswire-Asia/ -- NeoStem, Inc. (NYSE: NBS) ("NeoStem" or the "Company"), an international biopharmaceutical company with operations in the U.S. and China, announced today the appointment of Deloitte & Touche LLP ("Deloitte & Touche") as the Company's independent registered...

2010-03-16 21:15 572

Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2009 Results

NANJING, March 16 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group ("Simcere" or the "Company") (NYSE: SCR), a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported unaudited f...

2010-03-16 13:30 638

BMP Sunstone Reports Fourth Quarter and Full Year 2009 Financial Results

FY2009 Revenue of $146.9 Million, Adjusted EBITDA of $14.4 Million Continued Improvement in Revenue, Operating Income and Profit Performance PLYMOUTH MEETING, Pa., March 16 /PRNewswire-Asia/ -- BMP Sunstone Corporation (Nasdaq: BJGP) ("BMP Sunstone" or the "Company") today announced fina...

2010-03-16 04:01 847

Renhuang Schedules Conference Call to Discuss FY 2010 First Quarter Results

HARBIN, China, March 15 /PRNewswire-Asia/ -- Renhuang Pharmaceuticals, Inc. (Pink Sheets: RHGP) ("Renhuang" or the "Company"), a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines ("TCM") in China, today announced it will host a c...

2010-03-15 20:30 727

NeoStem Announces Presentation Time Change at Roth Capital Partners 22nd Annual OC Growth Stock Conference

NEW YORK, March 15 /PRNewswire-Asia/ -- NeoStem, Inc. (NYSE Amex: NBS) ("NeoStem" or the "Company"), an international biopharmaceutical company with operations in the U.S. and China, announced today a change for the Company's presentation at the Roth Capital Partners 22nd Annual OC Growth Stock ...

2010-03-15 20:00 657

Inadequate Response to Clopidogrel Leads to Higher Incidence of Major Adverse Cardiac Events in Patients Who have Undergone PCI

Results suggest increased need for quantifying patient response to clopidogrel through point-of-care testing SAN DIEGO, March 15 /PRNewswire-Asia/ -- Accumetrics, Inc., a privately-held developer and marketer of the VerifyNow(R) System, the first rapid and easy-to-use point-of-care system f...

2010-03-15 20:30 751

American Oriental Bioengineering Reports Fourth Quarter and Full Year 2009 Financial Results

NEW YORK, March 15 /PRNewswire-Asia-FirstCall/ -- American Oriental Bioengineering, Inc. (NYSE: AOB), ("the Company" or "AOBO"), a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the count...

2010-03-15 18:00 580

Thomson Reuters Names the World's 'Hottest' Researchers

PHILADELPHIA and LONDON, March 15 /PRNewswire-Asia/ -- The world's "hottest" researcher is biochemist Rudolf Jaenisch from the Massachusetts Institute of Technology. He is joined by scientists scattered from Ann Arbor to Osaka on the annual Thomson Reuters list of the world's 12 hottest resear...

2010-03-15 12:01 884

ACCORD Lipid Study Brings new Hope to People With Type 2 Diabetes and Atherogenic Dyslipidemia Says International Academic Foundation

ATLANTA, Georgia, March 15 /PRNewswire-AsiaNet/ -- Cardiovascular risk can be reduced by an additional 31 percent in type 2 diabetes patients with atherogenic dyslipidemia, the common combination of elevated triglycerides (TG, 204 mg/dL or 2.3 mmol/L or higher) and low levels of high-dens...

2010-03-19 02:48 825

TaiGen Announces Nemonoxacin (TG-873870) Once-A-Day Oral Dosing in Diabetic Foot Infection Met Primary Endpoints

Promising Anti-MRSA Activity and Excellent Pharmacokinetic Profile Demonstrated in a Phase II Proof of Concept trial TAIPEI, Taiwan, March 12 /PRNewswire-Asia/ -- TaiGen Biotechnology Co., Ltd. announced today the Phase II trial of nemonoxacin (TG-873870) in Diabetic Foot Infection (DFI) with...

2010-03-12 21:00 595

Renhuang Announces Price Increase on Shengmai Granules

HARBIN, China, March 12 /PRNewswire-Asia-FirstCall/ -- Renhuang Pharmaceuticals, Inc. (Pink Sheets: RHGP) ("Renhuang" or the "Company"), a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines ("TCM"), announced today that it has r...

2010-03-12 02:37 487

Tianyin Pharmaceutical Co., Inc. to Present at the 22nd Annual ROTH Capital Partners OC Growth Stock Conference on March 16

CHENGDU, China, March 12 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Alternext: TPI), a manufacturer and supplier of modernized traditional Chinese medicine ("TCM") based in Chengdu, China, today announced it will present at 22nd Annual ROTH Capital Partners (ROTH) OC G...

2010-03-12 02:30 616

China-Biotics, Inc. Announces the Results of the 2009 Annual Stockholders Meeting

SHANGHAI, March 10 /PRNewswire-Asia/ -- China-Biotics, Inc. ("China-Biotics", the "Company") (Nasdaq: CHBT), a leading developer, manufacturer and distributor of probiotics products in China, today announced the results of its 2009 Annual Meeting of Stockholders ("AGM") held on Friday, March 5, ...

2010-03-10 21:13 605

China Medicine Corporation Applies to List on NASDAQ Global Market

GUANGZHOU, China, March 10 /PRNewswire-Asia/ -- China Medicine Corporation (OTC Bulletin Board: CHME) ("China Medicine" or "the Company"), primarily a leading distributor and a developer of Western pharmaceuticals, traditional Chinese medicines ("TCM"), and other nutriceuticals, announced today ...

2010-03-10 21:00 665

Winner Medical Group Inc. to Present at the 22nd Annual ROTH Capital Partners OC Growth Stock Conference

SHENZHEN, China, March 10 /PRNewswire-Asia/ -- Winner Medical Group Inc. (NYSE: WWIN; "Winner Medical"), a manufacturer of medical dressings, medical disposables and non-woven PurCotton(R) materials for the medical and consumer products industries, today announced it will present at the 22nd Ann...

2010-03-10 20:29 692

Lotus Pharmaceuticals Reports Groundbreaking Ceremony

BEIJING, March 10 /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company"), a growing developer and producer of prescription drugs and licensed national seller of pharmaceutical products in the People's Republic of China ("PRC"), report...

2010-03-10 21:00 539

3SBio Announces Changes to its Board of Directors

SHENYANG, China, March 10 /PRNewswire-Asia/ -- 3SBio Inc. (Nasdaq: SSRX), a leading biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China, today announced changes to its board of directors (the "Board"). Ms. Liping Xu,...

2010-03-10 16:29 665

China VoIP & Digital Telecom Subsidiary, Beijing PowerUnique Technologies, Wins Virtualization Project Bid for Peking University's Third Hospital

JINAN, Shandong, China, March 10 /PRNewswire-Asia-FirstCall/ -- Beijing PowerUnique Technologies Co., Ltd ("BPUT"), one of the wholly-owned subsidiaries of China VoIP & Digital Telecom (OTC Bulletin Board: CVDT), today announced that it has won the bid for the Peking University Third Hospita...

2010-03-10 22:00 610

American Oriental Bioengineering to Report Fourth Quarter and Full Year 2009 Financial Results on March 15, 2010

NEW YORK, March 10 /PRNewswire-Asia-FirstCall/ -- American Oriental Bioengineering, Inc. (NYSE: AOB), ("the Company" or "AOBO"), a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the cou...

2010-03-10 21:00 470
1 ... 722723724725726727728 ... 838